Trial Profile
Effect of denosumab for the treatment of postmenoposal osteoporosis in woman caused by the loss of ovarian function due to gynecologic malignancies
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Nov 2019
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 27 Apr 2015 New trial record